Inhibition of the CEBPβ-NFκB interaction by nanocarrier-packaged Carnosic acid ameliorates glia-mediated neuroinflammation and improves cognitive function in an Alzheimer’s disease model. This evidence concerns the gene NFKB1 and early-onset autosomal dominant Alzheimer disease.